Junjie Liu | pharmaceutics | Best Researcher Award

Posted on by Shen Awards

Prof. Junjie Liu | pharmaceutics | Best Researcher Award

professor, Zhengzhou University, China

Liu Junjie is a professor and PhD supervisor at the School of Pharmacy, Zhengzhou University. 🎓 He completed his PhD in pharmaceutical sciences from Chongqing University in 2018. 📚 With over 40 publications in top journals like Sci Adv and Adv Mater, he is a recognized leader in his field. 🧬 He has led 10 major research projects, including grants from the National Natural Science Foundation of China. 🌍 Liu has received multiple prestigious honors, including youth talent support and high-level talent awards. 🚀 His contributions in pharmaceutical science are shaping the future of health and medicine.

Profile

Education🎓 

Liu Junjie obtained his PhD in pharmaceutical sciences from Chongqing University in 2018. 🏫 His advanced training in pharmaceutical sciences allowed him to develop expertise in drug development and pharmaceutical research. 📑 His education combined rigorous theoretical knowledge and hands-on experience in the laboratory, equipping him with the tools necessary for groundbreaking research. 🧪 He also pursued further professional development through leading postdoctoral research, continuously building on his PhD training. 💡 His academic foundation serves as the cornerstone for his innovative work in drug discovery and therapeutic development.

Experience🧑‍🏫 

Liu Junjie is currently a professor and PhD supervisor at Zhengzhou University’s School of Pharmacy. 🔬 He has extensive experience leading pharmaceutical research and managing collaborative research projects. 🧑‍🔬 Since completing his PhD, he has overseen 10 major research projects, including those supported by the National Natural Science Foundation of China. 🌟 His work has been featured in over 40 SCI-indexed publications as the first or corresponding author, showcasing his strong research output. 🌿 Liu is also actively involved in mentorship, guiding PhD students and shaping the next generation of pharmaceutical scientists.

Awards and Honors🏆

Liu Junjie has received numerous prestigious awards for his contributions to pharmaceutical research. 🎖️ Notably, he has been recognized by the China Association for Science and Technology with the Youth Talent Support award. 🌟 His high-level talent and innovative contributions to the field have earned him recognition in Henan Province, where he received the High-level Talent Award and was named an Outstanding Youth Talent in the Central Plains. 💼 Additionally, he was awarded the Innovative Talent Award for his role in advancing pharmaceutical research at Henan’s Higher Education Institutions.

Research Focus🔬 

Liu Junjie’s research focuses on the development of innovative drugs and therapeutic treatments. 🧪 His work aims to bridge the gap between basic pharmaceutical sciences and clinical applications, exploring drug delivery systems and novel therapeutic materials. 🧬 He is particularly interested in precision medicine and the design of targeted therapies to improve treatment efficacy and minimize side effects. 🌍 His interdisciplinary research integrates chemistry, biology, and materials science to advance drug development, leading to over 40 high-impact publications in renowned scientific journals. 📈 His research aims to transform healthcare and patient outcomes.

Publication Top Notes

In situ implantable DNA hydrogel for diagnosis and therapy of postoperative rehemorrhage following intracerebral hemorrhage surgery

Published in: Science Advances (2024, 10(33), ado3919)
Authors: Yu, W., Gong, E., Wang, C., Liu, J., Shi, J.
Overview: This research focuses on a DNA hydrogel that can be implanted in situ to diagnose and treat rehemorrhage after intracerebral hemorrhage surgery, providing a new tool for post-surgical care.

2. In situ formation of biohybrid system based on Streptococcus pneumoniae for enhanced radical therapy against tumors

Published in: Cell Reports Physical Science (2024, 5(7), 102074)
Authors: Zhao, X., Wang, Q., Dong, H., Liu, J., Shi, J.
Overview: The study explores a biohybrid system using Streptococcus pneumoniae for improved radical cancer therapies, targeting tumors more effectively.

3. Retraction Note: Copper-based metal-organic framework impedes triple-negative breast cancer metastasis via local estrogen deprivation and platelets blockade

Published in: Journal of Nanobiotechnology (2024, 22(1), pp. 302)
Authors: Wang, S., Yin, N., Li, Y., Si, P., Liu, J.
Overview: This article was retracted, but it originally examined how copper-based frameworks prevent breast cancer metastasis by blocking estrogen and platelets.

4. A Neutrophil Hijacking Nanoplatform Reprograming NETosis for Targeted Microglia Polarizing Mediated Ischemic Stroke Treatment

Published in: Advanced Science (2024, 11(17), 2305877)
Authors: Yin, N., Wang, W., Pei, F., Wang, Z.-H., Liu, J.
Overview: The research proposes a nanoplatform that hijacks neutrophils to treat ischemic stroke by modulating microglia polarization.

5. Ultrasensitive Optical Detection and Elimination of Residual Microtumors with a Postoperative Implantable Hydrogel Sensor for Preventing Cancer Recurrence

Published in: Advanced Materials (2024, 36(14), 2307923)
Authors: Geng, S., Guo, P., Wang, J., Shi, J., Liu, J.
Overview: This article focuses on an optical sensor integrated with a hydrogel to detect and remove microtumors post-surgery, reducing cancer recurrence risk.

6. Biomimetic Nanovehicle-Enabled Targeted Depletion of Intratumoral Fusobacterium nucleatum Synergizes with PD-L1 Blockade against Breast Cancer

Published in: ACS Nano (2024, 18(12), pp. 8971–8987)
Authors: Geng, S., Guo, P., Li, X., Liu, J., Yang, Y.
Overview: This study examines a nanovehicle that targets Fusobacterium nucleatum within tumors to boost the effectiveness of PD-L1 blockade therapies for breast cancer.

Conclusion

Liu Junjie is an excellent candidate for the Best Researcher Award. His robust academic output, leadership in research projects, mentorship, and numerous recognitions make him well-suited for this prestigious recognition. While expanding his international collaborations and increasing the practical application of his research could further enhance his candidacy, his contributions to pharmaceutical sciences and his leadership in innovative research projects make him a strong contender for this award.

 

Assist Prof Dr. Amjad Khan | Pharmacy | Best Researcher Award

Posted on by Shen Awards

Assist Prof Dr. Amjad Khan | Pharmacy | Best Researcher Award

Assistant Professor at Quaid-i-Azam University, Pakistan

👨‍🎓He remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 He successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Academic Record:

Assistant Professor Dr. Amjad Khan has a remarkable academic background, including a Ph.D. in Clinical Pharmacy from the School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM), Malaysia, awarded in 2019. His doctoral thesis was titled “Evaluation of time to achieve Dry Weight using Body Composition Monitor, Hypertension management and prevalence of Depression among Hemodialysis patients in Kelantan Malaysia.” Additionally, he holds an M.Phil. in Pharmaceutical Biotechnology from the Department of Biotechnology, Quaid-i-Azam University, Pakistan, completed in 2014, focusing on the isolation, structure elucidation, and biological activities of Acridocarpus Orientalis A. Juss. Furthermore, Dr. Khan achieved his Doctor of Pharmacy (Pharm.D.) from Gomal University, Pakistan, graduating with distinction (Gold Medal award) from the Faculty of Pharmacy in 2012, with an impressive percentage of 81% (A Grade). His earlier educational achievements include F. Sc (Pre-Medical) from BISE D.I.Khan, KP, Pakistan, in 2007, and S.S.C. (Science) from BISE Bannu, KP, Pakistan, in 2005.

Research Interest:

Assistant Professor Dr. Amjad Khan’s expertise spans several key areas within the field of healthcare. With a focus on infectious diseases, his knowledge and experience are invaluable in understanding and combating various infectious agents and their impact on public health. Additionally, his specialization in nephrology enables him to contribute significantly to the study and treatment of kidney-related conditions, particularly in the context of infectious diseases.

Professional Experience:

Assistant Professor Dr. Amjad Khan has been an integral part of the Department of Pharmacy at Quaid-i-Azam University in Islamabad, Pakistan, holding various academic positions:

  1. Assistant Professor (TTS), Department of Pharmacy Duration: From 22nd October 2019 to present.
  2. Assistant Professor (BPS), Department of Pharmacy Duration: From 12th June 2019 to 21st October 2019.
  3. Lecturer in Clinical Pharmacy, Department of Pharmacy Duration: From 27th April 2017 to 11th June 2019.

Administrative & Academic Assignment:

Dr. Amjad Khan has been actively involved in various academic and administrative roles at Quaid-i-Azam University, Islamabad, contributing to the development and management of educational processes and initiatives. His roles include:

  • Member of the Departmental Admission Committee for Undergraduate (Pharm.D.) Programs at Quaid-i-Azam University, Islamabad, since September 19, 2022.
  • WHO/EPI Polio Campaigns Focal Person for the Pharmacy Department at Quaid-i-Azam University, Islamabad, since August 17, 2022.
  • Member of the Teaching Evaluation Committee at Quaid-i-Azam University, Islamabad, since June 22, 2022.
  • Focal Person for the Higher Education Data Repository (HEDR) at Quaid-i-Azam University, Islamabad, since May 30, 2022.
  • Member of the Departmental Attendance Committee at Quaid-i-Azam University, Islamabad, since April 25, 2022.

Award & Honors:

  • Quaid-i-Azam University Best Performance Award for the year 2022-2023.
  • Gold Medal and Merit Certificate from Gomal University for securing First-Class First-Position in the Doctor of Pharmacy (Pharm.D.) Degree, Session (2007-2012).
  • Continuous Merit Scholarship throughout his Pharmacy Career.
  • Approval as an international supervisor by the University of Oslo, Norway; The University of Edinburgh, UK; and Universiti Sains Malaysia (USM), Malaysia, for assisting/co-supervising research students.
  • Six Months Research Fellowship at UoN Chair of Oman’s Medicinal Plants and Marine Natural Products, funded by the University of Nizwa, Sultanate of Oman.
  • Participation in the Prime Minister’s Fee Reimbursement and Laptop Distribution Scheme to facilitate talented graduates in improving Higher Education during the academic year 2013-14.

Publications:

From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS)

  • Published in Energy in 2017 with 126 citations.

Prevalence and predictors of depression among hemodialysis patients: a prospective follow-up study

  • Published in Energy in 2019 with 91 citations.

COVID‐19 vaccinations: The unknowns, challenges, and hopes

  • Published in Energy in 2022 with 86 citations.

Structural elucidation and bioassays of newly synthesized pentavalent antimony complexes

  • Published in Energy in 2017 with 47 citations.

Health-related quality of life and its predictors among adults living with HIV/AIDS and receiving antiretroviral therapy in Pakistan

  • Published in Energy in 2021 with 45 citations.

Polymer-based drug delivery: the quest for local targeting of inflamed intestinal mucosa

  • Published in Energy in 2017 with 36 citations.

Seimatoric acid and colletonoic acid: Two new compounds from the endophytic fungi, Seimatosporium sp. and Colletotrichum sp.

  • Published in Energy in 2014 with 30 citations.

Management of patient care in hemodialysis while focusing on cardiovascular disease events and the atypical role of hyper-and/or hypotension: a systematic review

  • Published in Energy in 2016 with 28 citations.

 

 

Assist Prof Dr. Mai Tawfik | Pharmaceutics

Posted on by Shen Awards
🎉🏆 Congratulations, Assist Prof Dr. Mai Tawfik , on Your Outstanding Achievement as the Best Researcher! 🏆🎉
Assist Prof Dr. Mai Tawfik : Leading Researcher in Pharmaceutics

Assistant Professor at Faculty of Pharmacy, Cairo university, Egypt

Your remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 Your successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Professional Experience:

Assistant Professor of Pharmaceutics, Faculty of Pharmacy, Cairo University (May 2021 – Present) In this role, He is actively engaged in teaching and research within the field of Pharmaceutics at Cairo University. His responsibilities include imparting knowledge to students and contributing to the advancement of pharmaceutical sciences.

Teaching and Research Assistant of Pharmaceutics, Faculty of Pharmacy, Cairo University (January 2013 – May 2021) During this period, He served as a Teaching and Research Assistant, gaining valuable experience in both academic instruction and research activities in the field of Pharmaceutics.

Education:

Doctor of Philosophy in Pharmaceutical Sciences, Faculty of Pharmacy, Cairo University (July 2018 – March 2021) I successfully completed my Ph.D., with a focus on “A Pharmaceutical Study on Certain Nanocarrier Systems for Enhancing Transdermal Drug Delivery.”

Master of Pharmaceutical Sciences, Faculty of Pharmacy, Cairo University (July 2013 – April 2018) I attained a Master’s degree, conducting a pharmaceutical study on controlled release oral formulations of a phosphodiesterase-5 inhibitor.

Bachelor of Pharmaceutical Sciences, Faculty of Pharmacy, Cairo University (Sep. 2007 – May 2012) I graduated with honors, achieving an excellent academic record and ranking fifth in the class.

Research Experience:

His research experience encompasses a wide range of pharmaceutical studies, including:

Formulation and evaluation of nanosuspension. Formulation and evaluation of various liposomal, invasomal, novasomal, terpesomal, and elastosomal dispersion systems. Formulation, characterization, and optimization of polymeric nanoparticles (lipomers and dendrimers). Formulation, characterization, and optimization of solid lipid nanoparticles and nanostructured lipid carriers.

Publications:

  1. Abdallah M, Mohamed AS, Tadros MI, El-Nabarawi M, Tawfik MA.
    Solusomes (novel Soluplus® enriched nano-vesicular carriers) for improving the oral bioavailability of Candesartan Cilexetil.
    Pharmaceutical Development and Technology. 2023.
    doi: 10.1080/10837450.2023.2289166
  2. El Taweel MM, Tawfik MA, Soliman K, Khattab MS, Farag MM.
    Tailoring of topically applied curcumin loaded pro-novasomes for skin cancer treatment: In-vitro characterization, statistical optimization and histopathological assessment of subcutaneous Ehrlich carcinoma mice model.
    Journal of Drug Delivery Science and Technology. 2023; 88: 104957.
    doi: 10.1016/j.jddst.2023.104957
  3. Tawfik MA, El Taweel MM, Farag MM, Shamsel-Din HA, Ibrahim AB.
    Sonophoresis-assisted transdermal delivery of antimigraine-loaded nanolipomers: Radio-tracking, histopathological assessment and in-vivo biodistribution study.
    Int J Pharm. 2023 Aug 20; 644:123338.
    doi: 10.1016/j.ijpharm.2023.123338
    PMID: 37607646.
  4. Abd-Elal RMA, Essawy AM, Salem MA, Elsayed M, Khalil MG, Abdelhakeem E, Ali NA, Tawfik MA.
    Formulation, optimization, in-vivo biodistribution studies and histopathological safety assessment of duloxetine HCl-loaded ultra-elastic nanovesicles for antidepressant effect after intranasal and transdermal delivery.
    Int J Pharm X. 2023 Jun 24;6: 100194.
    doi: 10.1016/j.ijpx.2023.100194
    PMID: 37434966; PMCID: PMC10331411.
  5. Tawfik MA, Eltaweel MM, Fatouh AM, Shamsel‑Din HA, Ibrahim AB.
    Brain targeting of zolmitriptan via transdermal terpesomes: statistical optimization and in vivo biodistribution study by 99mTc radiolabeling technique.
    Drug Deliv. and Transl. Res. 2023.
    doi: 10.1007/s13346-023-01373-0